Since 2013, we have been heavily investing in CRISPR/Cas9-based mouse model development, and have designed a unique offer, combining our:
- Expertise in model design
- Rigorous quality controls for mouse models
With the advantages of gene editing technologies, such as:
- Cost effectiveness
- Short development time
"We are applying CRISPR/Cas9 technology to create Knockouts and Knockins in outbred, and more fragile inbred genetic backgrounds such as C57BL/6."
You will benefit from:
- Three independent genetically modified lines
- Freedom to operate thanks to our unique IP portfolio, including a license from Broad Institute (MIT)
- Off-target measurement
- Short development time
CRISPR/Cas9-based mouse model development
Get in touch about
Let us know how we can help
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe